Last $360.67 USD
Change Today +6.97 / 1.97%
Volume 3.7M
BIIB On Other Exchanges
Symbol
Exchange
Mexico
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas F. Keller Ph.D.

Former Director and Chairman of Finance & Audit Committee, Biogen Idec Inc.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 3 different organizations across 6 different industries.

See Board Relationships
82--

Background*

Mr. Thomas F. Kellerm, Ph.D., is the Dean Emeritus of Fuqua School of Business of Duke University, Durham, North Carolina since September 2004. Dr. Keller has been a Director of Wendy's International Inc., since 1991. Dr. Keller serves as a Director of Nations Funds Inc., Nations Fund Portfolios Inc., Nations Annuity Funds, Nations Government Income Term Trust 2003 Inc., Nations Government Income Term Trust 2004,Inc, Mentor Institutional Trust, Cash Reserve Trust, Nations ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 781-464-2000
Fax: --

Board Members Memberships*

Former Director
1983-Present
Director
1991-Present
Director and Chairman of Audit Committee
1992-N/A
Former Director
1992-N/A
Former Director, Chairman of Audit Committee and Member of Governance Committee
1994-N/A
Former Director
1995-N/A
Former Director and Chairman of Audit Committee
1996-Present
Director and Chairman of Finance & Audit Committee
1996-N/A
Former Director and Chairman of Finance & Audit Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $360.67 USD +6.97

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Flemming Ornskov M.D., MBA, MPHManaging Director, Chief Executive Officer and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN IDEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.